Cargando…

Screening for gestational diabetes, Ahmedabad, India

OBJECTIVE: To implement a community-based screening and awareness-raising project for gestational diabetes in Ahmedabad, India. METHODS: The project took place between April 2016 and August 2019 in Ahmedabad. Medical college faculty members and medical officers trained 3582 paramedical staff on scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayak, Himanshu, Gadhavi, Rajendra, Solanki, Bhavin, Aroor, Bhagyalaxmi, Gameti, Hemant, Shringarpure, Kalpita S, Joshi, Jayun, Kazi, Zuveriya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306388/
https://www.ncbi.nlm.nih.gov/pubmed/35923278
http://dx.doi.org/10.2471/BLT.22.288045
_version_ 1784752527630139392
author Nayak, Himanshu
Gadhavi, Rajendra
Solanki, Bhavin
Aroor, Bhagyalaxmi
Gameti, Hemant
Shringarpure, Kalpita S
Joshi, Jayun
Kazi, Zuveriya
author_facet Nayak, Himanshu
Gadhavi, Rajendra
Solanki, Bhavin
Aroor, Bhagyalaxmi
Gameti, Hemant
Shringarpure, Kalpita S
Joshi, Jayun
Kazi, Zuveriya
author_sort Nayak, Himanshu
collection PubMed
description OBJECTIVE: To implement a community-based screening and awareness-raising project for gestational diabetes in Ahmedabad, India. METHODS: The project took place between April 2016 and August 2019 in Ahmedabad. Medical college faculty members and medical officers trained 3582 paramedical staff on screening for gestational diabetes. These paramedical staff tested all pregnant women 24–28 weeks gestation, who were attending village health and nutrition days – also called mamta days – in urban and rural health centres for routine antenatal care, for gestational diabetes. An oral glucose tolerance test was used and blood sugar ≥ 7.8 mmol/L was the cut-off for gestational diabetes. Women with gestational diabetes were referred for counselling and treatment and all women were followed until 6 weeks after delivery. FINDINGS: Of 53 522 pregnant women screened, 6786 (12.7%) had gestational diabetes and were referred for nutritional therapy or medication; 836 (12.3%) of these women started medication. There was no significant difference in the prevalence of stillbirths between women with gestational diabetes (0.8%; 54/6786) and women without (0.7%; 338/46 736; P-value: 0.51). Of the women on treatment, 38 had abnormal blood glucose after delivery and continued with the medication. Two women with gestational diabetes died; they had other associated co-morbidities – pre-eclampsia and anaemia. CONCLUSION: We found a high prevalence of gestational diabetes, indicating the need for gestational diabetes screening and implementation of this project on a larger scale. Gestational diabetes screening at the community level is operationally feasible using the existing human resources and infrastructure of the reproductive health programmes.
format Online
Article
Text
id pubmed-9306388
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher World Health Organization
record_format MEDLINE/PubMed
spelling pubmed-93063882022-08-02 Screening for gestational diabetes, Ahmedabad, India Nayak, Himanshu Gadhavi, Rajendra Solanki, Bhavin Aroor, Bhagyalaxmi Gameti, Hemant Shringarpure, Kalpita S Joshi, Jayun Kazi, Zuveriya Bull World Health Organ Research OBJECTIVE: To implement a community-based screening and awareness-raising project for gestational diabetes in Ahmedabad, India. METHODS: The project took place between April 2016 and August 2019 in Ahmedabad. Medical college faculty members and medical officers trained 3582 paramedical staff on screening for gestational diabetes. These paramedical staff tested all pregnant women 24–28 weeks gestation, who were attending village health and nutrition days – also called mamta days – in urban and rural health centres for routine antenatal care, for gestational diabetes. An oral glucose tolerance test was used and blood sugar ≥ 7.8 mmol/L was the cut-off for gestational diabetes. Women with gestational diabetes were referred for counselling and treatment and all women were followed until 6 weeks after delivery. FINDINGS: Of 53 522 pregnant women screened, 6786 (12.7%) had gestational diabetes and were referred for nutritional therapy or medication; 836 (12.3%) of these women started medication. There was no significant difference in the prevalence of stillbirths between women with gestational diabetes (0.8%; 54/6786) and women without (0.7%; 338/46 736; P-value: 0.51). Of the women on treatment, 38 had abnormal blood glucose after delivery and continued with the medication. Two women with gestational diabetes died; they had other associated co-morbidities – pre-eclampsia and anaemia. CONCLUSION: We found a high prevalence of gestational diabetes, indicating the need for gestational diabetes screening and implementation of this project on a larger scale. Gestational diabetes screening at the community level is operationally feasible using the existing human resources and infrastructure of the reproductive health programmes. World Health Organization 2022-08-01 2022-06-22 /pmc/articles/PMC9306388/ /pubmed/35923278 http://dx.doi.org/10.2471/BLT.22.288045 Text en (c) 2022 The authors; licensee World Health Organization. https://creativecommons.org/licenses/by/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode (https://creativecommons.org/licenses/by/3.0/igo/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
spellingShingle Research
Nayak, Himanshu
Gadhavi, Rajendra
Solanki, Bhavin
Aroor, Bhagyalaxmi
Gameti, Hemant
Shringarpure, Kalpita S
Joshi, Jayun
Kazi, Zuveriya
Screening for gestational diabetes, Ahmedabad, India
title Screening for gestational diabetes, Ahmedabad, India
title_full Screening for gestational diabetes, Ahmedabad, India
title_fullStr Screening for gestational diabetes, Ahmedabad, India
title_full_unstemmed Screening for gestational diabetes, Ahmedabad, India
title_short Screening for gestational diabetes, Ahmedabad, India
title_sort screening for gestational diabetes, ahmedabad, india
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306388/
https://www.ncbi.nlm.nih.gov/pubmed/35923278
http://dx.doi.org/10.2471/BLT.22.288045
work_keys_str_mv AT nayakhimanshu screeningforgestationaldiabetesahmedabadindia
AT gadhavirajendra screeningforgestationaldiabetesahmedabadindia
AT solankibhavin screeningforgestationaldiabetesahmedabadindia
AT aroorbhagyalaxmi screeningforgestationaldiabetesahmedabadindia
AT gametihemant screeningforgestationaldiabetesahmedabadindia
AT shringarpurekalpitas screeningforgestationaldiabetesahmedabadindia
AT joshijayun screeningforgestationaldiabetesahmedabadindia
AT kazizuveriya screeningforgestationaldiabetesahmedabadindia